The Patent Finder

Corsair Pharma, Inc.

28 patents currently held · Updated Nov 16, 2026
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
0
Ending by 2030
Jan 2034
Next term end

When these terms end

Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045

Fee deadlines

Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
  • 1 fee due Jan 9, 2027
    The maintenance fee for Treprostinil derivative compounds and methods of using same (US 10,344,012) comes due Jan 9, 2027. Unpaid by Jul 9, 2027, it lapses early.
  • 2 fees due Apr 22 to 30, 2027 · next Apr 22
  • 2 fees due May 5, 2027
  • 1 fee due Jul 9, 2027
    The maintenance fee for Treprostinil Derivatives and Compositions and Uses Thereof (US 11,866,402) comes due Jul 9, 2027. Unpaid by Jan 10, 2028, it lapses early.
  • 1 fee due Oct 16, 2027
    The maintenance fee for Treprostinil derivative compounds and methods of using same (US 11,958,822) comes due Oct 16, 2027. Unpaid by Apr 17, 2028, it lapses early.

Which patents, and when each one lapses · Pro

Recent changes

Nothing was recorded against this company's patents in the last 90 days.

Patents held now

Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.
PatentTitleStatus Expires Confidence
US 9,371,264Treprostinil derivative compounds and methods of using same
In force
 · From the USPTO record
In forceFrom the USPTO record
US 9,505,737Treprostinil derivative compounds and methods of using same
In force
 · From the USPTO record
In forceFrom the USPTO record
US 9,776,982Treprostinil derivative compounds and methods of using same
In force
 · From the USPTO record
In forceFrom the USPTO record
US 9,845,305Treprostinil derivative compounds and methods of using same
In force
 · From the USPTO record
In forceFrom the USPTO record
US 10,344,012Treprostinil derivative compounds and methods of using same
In force
 · From the USPTO record
In forceFrom the USPTO record
US 10,450,290Treprostinil derivative compounds and methods of using same
In force
 · From the USPTO record
In forceFrom the USPTO record
US 10,752,605Treprostinil derivative compounds and methods of using same
In force
 · From the USPTO record
In forceFrom the USPTO record
US 11,046,666Treprostinil derivative compounds and methods of using same
In force
 · From the USPTO record
In forceFrom the USPTO record
US 11,339,139Treprostinil derivative compounds and methods of using same
In force
 · From the USPTO record
In forceFrom the USPTO record
US 11,505,535Treprostinil derivative compounds and methods of using same
In force
 · From the USPTO record
In forceFrom the USPTO record
10 of 28 patents shown.
Pro members see all 28.
Pro members: see all 28 patents

Sources and methods

Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.

Published applications

US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.

2 pending · 2 no status recorded

List them

The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited